{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:45:32Z","timestamp":1793727932810,"version":"4.6.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00637"],"award-info":[{"award-number":["PI16\/00637"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00532"],"award-info":[{"award-number":["PI19\/00532"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD06\/0016\/1013"],"award-info":[{"award-number":["RD06\/0016\/1013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0021\/0023"],"award-info":[{"award-number":["RD12\/0021\/0023"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0009\/0017"],"award-info":[{"award-number":["RD16\/0009\/0017"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0009\/0021"],"award-info":[{"award-number":["RD16\/0009\/0021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011941","name":"Gobierno del Principado de Asturias","doi-asserted-by":"publisher","award":["GRUPIN14-028"],"award-info":[{"award-number":["GRUPIN14-028"]}],"id":[{"id":"10.13039\/100011941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011941","name":"Gobierno del Principado de Asturias","doi-asserted-by":"publisher","award":["IDI-2018-000152"],"award-info":[{"award-number":["IDI-2018-000152"]}],"id":[{"id":"10.13039\/100011941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00223-020-00777-1","type":"journal-article","created":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T03:02:41Z","timestamp":1605409361000},"page":"410-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Chronic Kidney Disease\u2014Mineral and Bone Disorders: Pathogenesis and Management"],"prefix":"10.1007","volume":"108","author":[{"given":"Jorge B.","family":"Cannata-And\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mart\u00edn-Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Mart\u00edn-V\u00edrgala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rodr\u00edguez-Carrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Joaqu\u00edn","family":"Bande-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Alonso-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4227-4144","authenticated-orcid":false,"given":"Natalia","family":"Carrillo-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,15]]},"reference":[{"key":"777_CR1","first-page":"147","volume-title":"Nefrolog\u00eda Cl\u00ednica, L","author":"J Cannata-Andia","year":"2015","unstructured":"Cannata-Andia J, Rodriguez-Garcia M (2015) Metabolismo Calcio-F\u00f3sforo y sus alteraciones. In: Avenda\u00f1o H (ed) Nefrolog\u00eda Cl\u00ednica, L. Editorial m\u00e9dicaPanamericana, Madrid, pp 147\u2013160"},{"key":"777_CR2","first-page":"117","volume-title":"Primer on metabolic bone diseases and disorders of mineral metabolism","author":"H J\u00fcppner","year":"2003","unstructured":"J\u00fcppner H, Kronenberg HM (2003) Parathyroid hormone. In: Favus MJ (ed) Primer on metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington, pp 117\u2013124"},{"key":"777_CR3","first-page":"430","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"WG Goodman","year":"2003","unstructured":"Goodman WG et al (2003) Renal osteodystrophy in adults and children. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington, pp 430\u2013447"},{"key":"777_CR4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/9781118453926.ch22","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"MJ Favus","year":"2013","unstructured":"Favus MJ, Goltzman D (2013) Regulation of calcium and magnesium. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Wiley-Blackwell, Hoboken, pp 171\u2013179"},{"issue":"5","key":"777_CR5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11914-017-0398-4","volume":"15","author":"CJ Vorland","year":"2017","unstructured":"Vorland CJ et al (2017) Effects of excessive dietary phosphorus intake on bone health. Curr Osteoporos Rep 15(5):473\u2013482","journal-title":"Curr Osteoporos Rep"},{"key":"777_CR6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-642-54637-2_16","volume-title":"Management of chronic kidney disease","author":"J Cannata Andia","year":"2014","unstructured":"Cannata Andia J et al (2014) Mineral and bone disorders in chronic kidney disease. In: Arici M (ed) Management of chronic kidney disease. Springer, Berlin, pp 223\u2013239"},{"issue":"11","key":"777_CR7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69(11):1945\u20131953","journal-title":"Kidney Int"},{"key":"777_CR8","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1-130","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"777_CR9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/039139880402701103","volume":"27","author":"GB Spasovski","year":"2004","unstructured":"Spasovski GB (2004) Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy. Int J Artif Organs 27(11):918\u2013923","journal-title":"Int J Artif Organs"},{"key":"777_CR10","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199559176.001.1","volume-title":"The spectrum of mineral and bone disorders in chronic kidney disease","author":"K Olgaard","year":"2010","unstructured":"Olgaard K, Salusky I, Silver J (2010) The spectrum of mineral and bone disorders in chronic kidney disease. Oxford University Press, Oxford"},{"issue":"6","key":"777_CR11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Ure\u00f1a Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90(6):1184\u20131190","journal-title":"Kidney Int"},{"issue":"Suppl 5","key":"777_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ndt\/15.suppl_5.2","volume":"15","author":"J Silver","year":"2000","unstructured":"Silver J (2000) Molecular mechanisms of secondary hyperparathyroidism. Nephrol Dial Transpl 15(Suppl 5):2\u20137","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"777_CR13","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","volume":"10","author":"PP Centeno","year":"2019","unstructured":"Centeno PP et al (2019) Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion. Nat Commun 10(1):4693","journal-title":"Nat Commun"},{"issue":"2","key":"777_CR14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<78::AID-SSU3>3.0.CO;2-Z","volume":"13","author":"Y Tominaga","year":"1997","unstructured":"Tominaga Y et al (1997) Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13(2):78\u201386","journal-title":"Semin Surg Oncol"},{"issue":"2","key":"777_CR15","first-page":"25","volume":"6","author":"V Lorenzo","year":"1986","unstructured":"Lorenzo V et al (1986) Prevalencia de las distintas formas histol\u00f3gicas de osteodistrofia renal, con especial referencia a la osteomalacia. Nefrolog\u00eda 6(2):25\u201333","journal-title":"Nefrolog\u00eda"},{"issue":"2","key":"777_CR16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000185718","volume":"53","author":"P Moriniere","year":"1989","unstructured":"Moriniere P et al (1989) Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum. Nephron 53(2):93\u2013101","journal-title":"Nephron"},{"issue":"2","key":"777_CR17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"DJ Sherrard","year":"1993","unstructured":"Sherrard DJ et al (1993) The spectrum of bone disease in end-stage renal failure\u2013an evolving disorder. Kidney Int 43(2):436\u2013442","journal-title":"Kidney Int"},{"issue":"4","key":"777_CR18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","volume":"44","author":"G Hercz","year":"1993","unstructured":"Hercz G et al (1993) Aplastic osteodystrophy without aluminum: the role of \u201csuppressed\u201d parathyroid function. Kidney Int 44(4):860\u2013866","journal-title":"Kidney Int"},{"issue":"5","key":"777_CR19","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","volume":"47","author":"A Torres","year":"1995","unstructured":"Torres A et al (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47(5):1434\u20131442","journal-title":"Kidney Int"},{"issue":"2","key":"777_CR20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","volume":"19","author":"A Ferreira","year":"2008","unstructured":"Ferreira A et al (2008) Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol 19(2):405\u2013412","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"777_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31\u201338","journal-title":"Kidney Int"},{"issue":"1","key":"777_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M et al (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336","journal-title":"Kidney Int"},{"issue":"2 Suppl 1","key":"777_CR23","first-page":"S1","volume":"39","author":"Kidney Disease Outcome Quality Initiative","year":"2002","unstructured":"Kidney Disease Outcome Quality Initiative (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-266","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"777_CR24","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fernandez-Martin","year":"2015","unstructured":"Fernandez-Martin JL et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transpl 30(9):1542\u20131551","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"777_CR25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ndt\/gfy093","volume":"34","author":"JL Fernandez-Martin","year":"2019","unstructured":"Fernandez-Martin JL et al (2019) Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. Nephrol Dial Transpl 34(4):673\u2013681","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"777_CR26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52(3):519\u2013530","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"777_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone\u00a0disorder (CKD-MBD). Kidney Int Suppl 7(1):1\u201359","journal-title":"Kidney Int Suppl"},{"key":"777_CR28","doi-asserted-by":"crossref","unstructured":"Bover J et al (2021) The non-invasive diagnosis of bone disorders in CKD. Calcif Tissue Int. (in press)","DOI":"10.1007\/s00223-020-00781-5"},{"key":"777_CR29","doi-asserted-by":"crossref","unstructured":"Pimentel A et al (2021) Bone fragility fractures in CKD patients. Calcif Tissue Int. (in press)","DOI":"10.1007\/s00223-020-00779-z"},{"issue":"2","key":"777_CR30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-014-2813-3","volume":"26","author":"RC Bucur","year":"2015","unstructured":"Bucur RC et al (2015) Low bone mineral density and fractures in stages 3\u20135 CKD: an updated systematic review and meta-analysis. Osteoporos Int 26(2):449\u2013458","journal-title":"Osteoporos Int"},{"key":"777_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","volume":"22","author":"BC Silva","year":"2015","unstructured":"Silva BC, Bilezikian JP (2015) Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol 22:41\u201350","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"777_CR32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM et al (2016) Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67(4):559\u2013566","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"777_CR33","first-page":"49","volume":"109","author":"E Ritz","year":"2012","unstructured":"Ritz E et al (2012) Phosphate additives in food\u2013a health risk. Dtsch Arztebl Int 109(4):49\u201355","journal-title":"Dtsch Arztebl Int"},{"key":"777_CR34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.185","volume":"84","author":"JB Cannata-Andia","year":"2013","unstructured":"Cannata-Andia JB et al (2013) Use of phosphate-binding agents is associated with a lower risk of mortality. Kidney Int 84:998\u20131008","journal-title":"Kidney Int"},{"issue":"3","key":"777_CR35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nefro.2017.09.011","volume":"38","author":"P Mendez-Chacon","year":"2018","unstructured":"Mendez-Chacon P et al (2018) Influencia de la sobrecarga de calcio sobre el metabolismo \u00f3seo y mineral en 55 centros de hemodi\u00e1lisis de Lima. Nefrologia 38(3):279\u2013285","journal-title":"Nefrologia"},{"issue":"2","key":"777_CR36","first-page":"141","volume":"18","author":"D Alvarez-Hernandez","year":"2005","unstructured":"Alvarez-Hernandez D et al (2005) Long-term response of cultured rat parathyroid glands to calcium and calcitriol: the effect of cryopreservation. J Nephrol 18(2):141\u2013147","journal-title":"J Nephrol"},{"issue":"Suppl 1","key":"777_CR37","first-page":"3","volume":"31","author":"JV Torregrosa","year":"2011","unstructured":"Torregrosa JV et al (2011) Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.\u2013M.B.D.). Nefrologia 31(Suppl 1):3\u201332","journal-title":"Nefrologia"},{"issue":"6","key":"777_CR38","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","volume":"26","author":"J Floege","year":"2011","unstructured":"Floege J et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transpl 26(6):1948\u20131955","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"777_CR39","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","volume":"26","author":"M Naves-Diaz","year":"2011","unstructured":"Naves-Diaz M et al (2011) Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transpl 26(6):1938\u20131947","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"777_CR40","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1093\/ndt\/gfn338","volume":"23","author":"N Carrillo-Lopez","year":"2008","unstructured":"Carrillo-Lopez N et al (2008) Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol. Nephrol Dial Transpl 23(11):3479\u20133484","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"777_CR41","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/ndt\/gfs418","volume":"28","author":"JL Fernandez-Martin","year":"2013","unstructured":"Fernandez-Martin JL et al (2013) COSMOS: the dialysis scenario of CKD-MBD in Europe. Nephrol Dial Transpl 28(7):1922\u20131935","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"777_CR42","first-page":"458","volume":"18","author":"M Rodriguez Garcia","year":"2005","unstructured":"Rodriguez Garcia M, Naves Diaz M, Cannata Andia JB (2005) Bone metabolism, vascular calcifications and mortality: associations beyond mere coincidence. J Nephrol 18(4):458\u2013463","journal-title":"J Nephrol"},{"issue":"3","key":"777_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000323434","volume":"20","author":"P Roman-Garcia","year":"2011","unstructured":"Roman-Garcia P et al (2011) Vascular calcification in patients with chronic kidney disease: types, clinical impact and pathogenesis. Med Princ Pract 20(3):203\u2013212","journal-title":"Med Princ Pract"},{"issue":"8","key":"777_CR44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/sj.ki.5000297","volume":"69","author":"K Lomashvili","year":"2006","unstructured":"Lomashvili K, Garg P, O\u2019Neill WC (2006) Chemical and hormonal determinants of vascular calcification in vitro. Kidney Int 69(8):1464\u20131470","journal-title":"Kidney Int"},{"issue":"12","key":"777_CR45","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ki.2010.334","volume":"78","author":"WC O'Neill","year":"2010","unstructured":"O\u2019Neill WC, Lomashvili KA (2010) Recent progress in the treatment of vascular calcification. Kidney Int 78(12):1232\u20131239","journal-title":"Kidney Int"},{"issue":"3","key":"777_CR46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/HYPERTENSIONAHA.110.152058","volume":"56","author":"AC Montezano","year":"2010","unstructured":"Montezano AC et al (2010) Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 56(3):453\u2013462","journal-title":"Hypertension"},{"issue":"6","key":"777_CR47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10157-009-0208-0","volume":"13","author":"S Mune","year":"2009","unstructured":"Mune S et al (2009) Mechanism of phosphate-induced calcification in rat aortic tissue culture: possible involvement of Pit-1 and apoptosis. Clin Exp Nephrol 13(6):571\u2013577","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"777_CR48","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ki.2008.644","volume":"75","author":"CM Giachelli","year":"2009","unstructured":"Giachelli CM (2009) The emerging role of phosphate in vascular calcification. Kidney Int 75(9):890\u2013897","journal-title":"Kidney Int"},{"issue":"5","key":"777_CR49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ki.2010.461","volume":"79","author":"WC O'Neill","year":"2011","unstructured":"O\u2019Neill WC et al (2011) Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79(5):512\u2013517","journal-title":"Kidney Int"},{"key":"777_CR50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2020.03.007","volume":"306","author":"R Villa-Bellosta","year":"2020","unstructured":"Villa-Bellosta R (2020) New insights into endogenous mechanisms of protection against arterial calcification. Atherosclerosis 306:68\u201374","journal-title":"Atherosclerosis"},{"issue":"11","key":"777_CR51","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/ndt\/gfr591","volume":"26","author":"JB Cannata-Andia","year":"2011","unstructured":"Cannata-Andia JB, Roman-Garcia P, Hruska K (2011) The connections between vascular calcification and bone health. Nephrol Dial Transpl 26(11):3429\u20133436","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"777_CR52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfn466","volume":"24","author":"M Rodriguez-Garcia","year":"2009","unstructured":"Rodriguez-Garcia M et al (2009) Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transpl 24(1):239\u2013246","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"777_CR53","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ndt\/gfq491","volume":"26","author":"G Asci","year":"2011","unstructured":"Asci G et al (2011) The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. Nephrol Dial Transpl 26(3):1010\u20131015","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"777_CR54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-Lopez","year":"2016","unstructured":"Carrillo-Lopez N et al (2016) Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int 90(1):77\u201389","journal-title":"Kidney Int"},{"key":"777_CR55","doi-asserted-by":"crossref","unstructured":"Carrillo-Lopez N et al (2021) Role of the RANK\/RANKL\/OPG and Wnt\/\u00df-catenin systems in CKD Bone and cardiovascular disorders. Calcif Tissue Int. (in press)","DOI":"10.1007\/s00223-020-00803-2"},{"issue":"5","key":"777_CR56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nm.4076","volume":"22","author":"J Luo","year":"2016","unstructured":"Luo J et al (2016) LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption. Nat Med 22(5):539\u2013546","journal-title":"Nat Med"},{"key":"777_CR57","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1046\/j.1523-1755.63.s84.25.x","volume":"84","author":"GM London","year":"2003","unstructured":"London GM et al (2003a) Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int Suppl 84:S88-93","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"777_CR58","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM et al (2003b) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl 18(9):1731\u20131740","journal-title":"Nephrol Dial Transpl"},{"key":"777_CR59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2018.02.021","volume":"271","author":"P Raggi","year":"2018","unstructured":"Raggi P (2018) Atherosclerosis imaging to refine cardiovascular risk assessment in diabetic patients: computed tomography and positron emission tomography applications. Atherosclerosis 271:77\u201383","journal-title":"Atherosclerosis"},{"issue":"45","key":"777_CR60","first-page":"98","volume":"9","author":"P Raggi","year":"2010","unstructured":"Raggi P, Achenbach S (2010) Computed tomography for atherosclerosis and coronary artery disease imaging. Discov Med 9(45):98\u2013104","journal-title":"Discov Med"},{"issue":"5","key":"777_CR61","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.hco.0000172704.83016.26","volume":"20","author":"A Bellasi","year":"2005","unstructured":"Bellasi A, Raggi P (2005) Diagnostic and prognostic value of coronary artery calcium screening. Curr Opin Cardiol 20(5):375\u2013380","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"777_CR62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(97)00106-8","volume":"132","author":"LI Kauppila","year":"1997","unstructured":"Kauppila LI et al (1997) New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132(2):245\u2013250","journal-title":"Atherosclerosis"},{"key":"777_CR63","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gfh217","volume":"19","author":"T Adragao","year":"2004","unstructured":"Adragao T et al (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transpl 19:1480\u20131488","journal-title":"Nephrol Dial Transpl"},{"key":"777_CR64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/med\/9780199559176.003.019","volume-title":"The spectrum of mineral and bone disorders in chronic kidney disease","author":"M Ketteler","year":"2010","unstructured":"Ketteler M, Floege J (2010) Clinical management of vascular and soft tissue calcifications in chronic kidney disease patients. In: Olgaard K, Salusky I, Silver J (eds) The spectrum of mineral and bone disorders in chronic kidney disease. Oxford University Press, Oxford, pp 317\u2013331"},{"issue":"19","key":"777_CR65","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1111\/bph.15163","volume":"177","author":"J Perell\u00f3","year":"2020","unstructured":"Perell\u00f3 J et al (2020) Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis. Br J Pharmacol 177(19):4400\u20134415","journal-title":"Br J Pharmacol"},{"issue":"9","key":"777_CR66","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.119.044195","volume":"141","author":"P Raggi","year":"2020","unstructured":"Raggi P et al (2020) Slowing progression of cardiovascular calcification with SNF472 in patients on hemodialysis: results of a randomized phase 2b study. Circulation 141(9):728\u2013739","journal-title":"Circulation"},{"key":"777_CR67","doi-asserted-by":"crossref","unstructured":"Fusaro M et al (2021) Vitamin K in CKD bone disordes. Calcif Tissue Int. (in press)","DOI":"10.1007\/s00223-020-00792-2"},{"issue":"18","key":"777_CR68","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMra1505292","volume":"378","author":"SU Nigwekar","year":"2018","unstructured":"Nigwekar SU, Thadhani R, Brandenburg VM (2018) Calciphylaxis. N Engl J Med 378(18):1704\u20131714","journal-title":"N Engl J Med"},{"issue":"3","key":"777_CR69","first-page":"329","volume":"32","author":"JV Torregrosa","year":"2012","unstructured":"Torregrosa JV et al (2012) Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. Nefrologia 32(3):329\u2013334","journal-title":"Nefrologia"},{"key":"777_CR70","unstructured":"Torregrosa JV, Cucchiari D (2018) 50 key questions on Calciphylaxis. In: Permanyer P (ed) Chronic kidney disease, Barcelona"},{"issue":"3","key":"777_CR71","first-page":"166","volume":"10","author":"S Ong","year":"2012","unstructured":"Ong S, Coulson IH (2012) Diagnosis and treatment of calciphylaxis. Skinmed 10(3):166\u2013170","journal-title":"Skinmed"},{"issue":"5","key":"777_CR72","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.09671010","volume":"6","author":"RP Singh","year":"2011","unstructured":"Singh RP, Derendorf H, Ross EA (2011) Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis. Clin J Am Soc Nephrol 6(5):1155\u20131159","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"777_CR73","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00044011-200626040-00006","volume":"26","author":"T Ariyoshi","year":"2006","unstructured":"Ariyoshi T et al (2006) Effect of etidronic acid on arterial calcification in dialysis patients. Clin Drug Investig 26(4):215\u2013222","journal-title":"Clin Drug Investig"},{"issue":"6","key":"777_CR74","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ki.2008.663","volume":"75","author":"EG Neven","year":"2009","unstructured":"Neven EG, De Broe ME, D\u2019Haese PC (2009) Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? Kidney Int 75(6):580\u2013582","journal-title":"Kidney Int"},{"issue":"9","key":"777_CR75","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.ki.5001899","volume":"70","author":"V Persy","year":"2006","unstructured":"Persy V, De Broe M, Ketteler M (2006) Bisphosphonates prevent experimental vascular calcification: treat the bone to cure the vessels? Kidney Int 70(9):1537\u20131538","journal-title":"Kidney Int"},{"issue":"1","key":"777_CR76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ajkd.2009.12.039","volume":"56","author":"ND Toussaint","year":"2010","unstructured":"Toussaint ND et al (2010) Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis 56(1):57\u201368","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"777_CR77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5301\/jn.5000212","volume":"26","author":"JB Cannata-Andia","year":"2013","unstructured":"Cannata-Andia JB, Rodriguez Garcia M, Gomez Alonso C (2013) Osteoporosis and adynamic bone in chronic kidney disease. J Nephrol 26(1):73\u201380","journal-title":"J Nephrol"},{"key":"777_CR78","first-page":"1","volume":"843","author":"World Health Organ","year":"1994","unstructured":"World Health Organ (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1\u2013129","journal-title":"World Health Organ Tech Rep Ser"},{"key":"777_CR79","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","volume":"382","author":"SA Jamal","year":"2013","unstructured":"Jamal SA et al (2013) Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382:1268\u20131277","journal-title":"Lancet"},{"issue":"5","key":"777_CR80","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.nefro.2017.12.006","volume":"38","author":"J Bover","year":"2018","unstructured":"Bover J et al (2018) Osteoporosis, bone mineral density and CKD-MBD complex (I): diagnostic considerations. Nefrologia 38(5):476\u2013490","journal-title":"Nefrologia"},{"issue":"3","key":"777_CR81","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nefro.2018.10.009","volume":"39","author":"J Bover","year":"2019","unstructured":"Bover J et al (2019) Osteoporosis, bone mineral density and CKD-MBD (II): therapeutic implications. Nefrologia 39(3):227\u2013242","journal-title":"Nefrologia"},{"issue":"5","key":"777_CR82","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/kisup.2013.93","volume":"3","author":"JJ Kazama","year":"2013","unstructured":"Kazama JJ, Iwasaki Y, Fukagawa M (2013) Uremic osteoporosis. Kidney Int Suppl 3(5):446\u2013450","journal-title":"Kidney Int Suppl"},{"key":"777_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa192","author":"P Evenepoel","year":"2019","unstructured":"Evenepoel P et al (2019) European consensus statement on the diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfaa192","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"777_CR84","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1046\/j.1523-1755.2003.00005.x","volume":"63","author":"E Hern\u00e1ndez","year":"2003","unstructured":"Hern\u00e1ndez E et al (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63(6):2269\u20132274","journal-title":"Kidney Int"},{"issue":"2","key":"777_CR85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2015.156","volume":"88","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel P, D\u2019Haese P, Brandenburg V (2015) Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88(2):235\u2013240","journal-title":"Kidney Int"},{"key":"777_CR86","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cca.2020.05.023","volume":"508","author":"L Pereira","year":"2020","unstructured":"Pereira L, Fraz\u00e3o JM (2020) The bone-vessel axis in chronic kidney disease: an update on biochemical players and its future role in laboratory medicine. Clin Chim Acta 508:221\u2013227","journal-title":"Clin Chim Acta"},{"issue":"15","key":"777_CR87","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s40265-020-01364-2","volume":"80","author":"NR Fuggle","year":"2020","unstructured":"Fuggle NR et al (2020) Assessment of cardiovascular safety of anti-osteoporosis drugs. Drugs 80(15):1537\u20131552","journal-title":"Drugs"},{"key":"777_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay6570","author":"J Bovijn","year":"2020","unstructured":"Bovijn J et al (2020) Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aay6570","journal-title":"Sci Transl Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00777-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-020-00777-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00777-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T06:05:52Z","timestamp":1697090752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-020-00777-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,15]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00777-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,15]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author(s) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}